Mobia Medical counsel buys 2,000 shares at $10.30

Mobia Medical’s General Counsel reported an open-market share purchase, increasing direct holdings to 5,000 shares.

Rhea-AI Filing Summary

Mobia Medical, Inc. (MOBI) insider Chase C. Leavitt, the company’s General Counsel and Corporate Secretary, purchased 2,000 shares of common stock on September 11, 2026 in a purchase described as an open market or private transaction at $10.30 per share. Following this transaction, Leavitt directly holds 5,000 Mobia Medical common shares. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Net Buyer: 2,000 shares

Net Buy 1 txn

Insider Leavitt Chase C.

Role SEE REMARKS

Bought 2,000 shs ($21K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	2,000	$10.30	$21K

Holdings After Transaction: Common Stock — 5,000 shares (Direct)

Key Figures

Shares purchased: 2,000 shares Purchase price per share: $10.30 per share Shares owned after transaction: 5,000 shares +1 more

4 metrics

Shares purchased 2,000 shares Common stock bought on September 11, 2026

Purchase price per share $10.30 per share Price for the September 11, 2026 common stock purchase

Shares owned after transaction 5,000 shares Direct Mobia Medical common stock holdings after the reported purchase

Net shares bought 2,000 shares Net buy shares reported in the transaction summary

Key Terms

Rule 10b5-1, open market or private transaction, direct ownership

3 terms

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for this transaction"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open market or private transaction financial

"Purchase in open market or private transaction"

direct ownership financial

"The reporting person holds these shares as direct ownership"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Mobia Medical (MOBI) report on this Form 4?

Mobia Medical reported that Chase C. Leavitt purchased 2,000 shares of Mobia Medical common stock on September 11, 2026 in a transaction described as an open market or private transaction.

At what price did the Mobia Medical (MOBI) insider buy shares?

Chase C. Leavitt bought 2,000 shares of Mobia Medical common stock at $10.30 per share in a purchase described as an open market or private transaction.

How many Mobia Medical (MOBI) shares does the insider own after this transaction?

After the reported purchase, Chase C. Leavitt directly holds 5,000 shares of Mobia Medical common stock, according to the Form 4.

Was the Mobia Medical (MOBI) insider trade made under a Rule 10b5-1 plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not selected, so no Rule 10b5-1 trading plan is reported for this transaction.

What is the role of the reporting person in Mobia Medical (MOBI)?

The reporting person, Chase C. Leavitt, serves as Mobia Medical’s General Counsel and Corporate Secretary, as noted in the remarks to the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 04:35 PM Accepted by SEC EDGAR 09/15/2026 - 04:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leavitt Chase C.

(Last) (First) (Middle)

2802 FLINTROCK TRACE, SUITE 226

(Street)

AUSTIN TEXAS 78738

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Mobia Medical, Inc. [ MOBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEE REMARKS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		P		2,000	A	$10.3	5,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

General Counsel and Corporate Secretary

	/s/ Chase Leavitt	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)